Spruce biosciences announces reverse stock split

South san francisco, calif.--(business wire)--spruce biosciences, inc. (otcqb: sprb), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that it will implement a 1-for-75 reverse stock split of its issued and outstanding shares of common stock (“reverse stock split”), effective at 5:00 p.m. eastern time on august 4, 2025. the reverse stock split was approved by the compa.
SPRB Ratings Summary
SPRB Quant Ranking